Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729740 · ClinicalTrials.gov registry record · NA
Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil
A NA study of Intracranial Aneurysm, sponsored by Penumbra.
- Completed
- Registry status
- NA
- Development phase
- 995
- Enrollment target
- 20
- Study locations
NCT02729740 is a NA study of Intracranial Aneurysm that has completed, run by Penumbra. The registered enrollment target is 995 participants, below the 9,125-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (89% lower). The trial reports 20 study locations across 6 states.
The verdict
NCT02729740, a NA study of Intracranial Aneurysm, has completed, sponsored by Penumbra.
- COMPLETED
- Registry status
- NA
- Development phase
- 995 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to gather post market data on the Penumbra SMART COIL® System (Smart System) in the treatment of intracranial aneurysms and other malformations.
Conditions Studied
Interventions
- DEVICE Penumbra Smart Coil
- DEVICE Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD)
Study Locations (20)
Florida
- Lawnwood Regional Medical Center - Ft. Pierce
- CARE - Palmetto - Hialeah
- Memorial Healthcare System - Hollywood
- Baptist Medical Center - Jacksonville
- Mayo Clinic Jacksonville - Jacksonville
- Jackson Memorial - Miami
Arizona
- Banner Desert Medical Center - Mesa
- Banner University Medical Center - Phoenix - Phoenix
- BNI - Phoenix
- Banner - University Medical Center Tucson - Tucson
California
- Community Regional - Fresno
- Loma Linda Medical Center - Loma Linda
- Mercy San Juan - Sacramento
- Cottage Hospital - Santa Barbara
Colorado
- University of Colorado - Aurora
- RIA - Swedish Medical Center - Englewood
- St. Anthony's Hospital - Lakewood
- RIA - Lutheran Medical Center - Wheat Ridge
Alabama
- Southeast Alabama Medical Center - Dothan
Delaware
- Christiana Health - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 995 participants |
| Start Date | 2016-06-03 |
| Est. Completion | 2019-12-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729740
The ClinicalTrials.gov registry entry for NCT02729740 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 995 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,125-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (89% lower). The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Penumbra Smart Coil is the first listed.
NCT02729740 reports 20 study locations spanning 6 distinct geographic areas - top geographies include Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT02729740 about?
NCT02729740 is a clinical study titled "Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil". The primary objective of this study is to gather post market data on the Penumbra SMART COIL® System (Smart System) in the treatment of intracranial aneurysms and other malformations.
What is the current status of trial NCT02729740?
This trial is currently completed. It is a NA study. The enrollment target is 995 participants. The study started on 2016-06-03. Estimated completion is 2019-12-27.
What conditions does trial NCT02729740 study?
This clinical trial studies the following conditions: Intracranial Aneurysm.
What interventions are being tested in trial NCT02729740?
The interventions under investigation include: Penumbra Smart Coil (DEVICE), Penumbra Coil 400TM (PC400), Penumbra Occlusion DeviceTM(POD) (DEVICE).
Who is sponsoring clinical trial NCT02729740?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02729740 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intracranial Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
RECRUITING · NA
-
MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study
ACTIVE NOT RECRUITING · NA
-
Neuroform Atlas Stent System Study
COMPLETED · NA
-
Product Surveillance Registry
RECRUITING
-
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
RECRUITING
-
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.